Product Code: ETC6186173 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The neurovascular embolization devices market in Australia focuses on the use of devices that block or occlude blood vessels within the brain to treat conditions like aneurysms, AVMs, and tumors. These devices, including coils, plugs, and liquid embolic agents, are integral to the growing field of minimally invasive neurointerventional procedures. The market is benefiting from advances in embolization techniques that allow for more precise targeting and better clinical outcomes. The increasing demand for less invasive treatment options and the rising number of neurovascular interventions contribute to the growth of this market.
In Australia, the neurovascular embolization devices market is growing due to the rising number of interventions aimed at treating cerebral aneurysms, arteriovenous malformations, and other neurovascular conditions. The trend is toward the development of embolization devices that provide more precise control over the embolization process, leading to better patient outcomes. There is also a shift toward the use of bioresorbable embolic agents, which are gaining traction due to their potential to reduce long-term complications. Additionally, advancements in imaging technology are allowing for real-time monitoring during embolization procedures, enhancing their effectiveness.
Challenges in the neurovascular embolization devices market include the technical complexity of embolization procedures, risks of procedural failure, and cautious adoption rates in less urbanized regions where advanced neurointerventional care is limited.
Embolization devices are integral in treating vascular abnormalities such as AVMs and aneurysms, and Australias progressive healthcare system is adopting these at a rapid pace. Investments in bioresorbable coils, liquid embolics, and embolic microspheres can yield high returns. This market is also benefiting from supportive policies aimed at reducing surgical burden and improving neurological outcomes.
The TGA oversees embolization device approvals under its high-risk classification. The Australian government is investing in improving stroke intervention pathways, indirectly promoting the usage of embolization devices by funding specialized stroke units and increasing clinical training.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Neurovascular Embolization Devices Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Neurovascular Embolization Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Neurovascular Embolization Devices Market - Industry Life Cycle |
3.4 Australia Neurovascular Embolization Devices Market - Porter's Five Forces |
3.5 Australia Neurovascular Embolization Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Neurovascular Embolization Devices Market Revenues & Volume Share, By Process, 2021 & 2031F |
3.7 Australia Neurovascular Embolization Devices Market Revenues & Volume Share, By Therapeutic Applications, 2021 & 2031F |
3.8 Australia Neurovascular Embolization Devices Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Australia Neurovascular Embolization Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Neurovascular Embolization Devices Market Trends |
6 Australia Neurovascular Embolization Devices Market, By Types |
6.1 Australia Neurovascular Embolization Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Embolic Coils, 2021- 2031F |
6.1.4 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Bare Detachable Coils, 2021- 2031F |
6.1.5 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Coated Detachable Coils, 2021- 2031F |
6.1.6 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Flow Diversion Devices, 2021- 2031F |
6.1.7 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Liquid Embolic Agents, 2021- 2031F |
6.1.8 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Cerebral Balloon Angioplasty and Stenting Systems, 2021- 2031F |
6.1.9 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Neurovascular Embolization Devices Market, By Process |
6.2.1 Overview and Analysis |
6.2.2 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Neurothrombectomy, 2021- 2031F |
6.2.3 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Cerebral Angiography, 2021- 2031F |
6.2.4 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Carotid Endarterectomy, 2021- 2031F |
6.2.5 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Stenting, 2021- 2031F |
6.2.6 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Microsurgical Clipping, 2021- 2031F |
6.2.7 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Coiling, 2021- 2031F |
6.3 Australia Neurovascular Embolization Devices Market, By Therapeutic Applications |
6.3.1 Overview and Analysis |
6.3.2 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Brain Aneurysm, 2021- 2031F |
6.3.3 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Stenosis, 2021- 2031F |
6.3.4 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Ischemic Strokes, 2021- 2031F |
6.4 Australia Neurovascular Embolization Devices Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.4.4 Australia Neurovascular Embolization Devices Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Australia Neurovascular Embolization Devices Market Import-Export Trade Statistics |
7.1 Australia Neurovascular Embolization Devices Market Export to Major Countries |
7.2 Australia Neurovascular Embolization Devices Market Imports from Major Countries |
8 Australia Neurovascular Embolization Devices Market Key Performance Indicators |
9 Australia Neurovascular Embolization Devices Market - Opportunity Assessment |
9.1 Australia Neurovascular Embolization Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Neurovascular Embolization Devices Market Opportunity Assessment, By Process, 2021 & 2031F |
9.3 Australia Neurovascular Embolization Devices Market Opportunity Assessment, By Therapeutic Applications, 2021 & 2031F |
9.4 Australia Neurovascular Embolization Devices Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Australia Neurovascular Embolization Devices Market - Competitive Landscape |
10.1 Australia Neurovascular Embolization Devices Market Revenue Share, By Companies, 2024 |
10.2 Australia Neurovascular Embolization Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |